Kala Pharmaceuticals Inc.
KALA
|
|
| |
|
| Trading Volume | 848 |
|
|
13.42 - 4.61 |
| Market Cap Full | $ 16.5M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 11.6% | 12.1% | -60.6% | 14.1% |
| Q2 | - | -12.7% | -3.1% | -78.3% |
| Q3 | - | -7.1% | -39% | 3583.3% |
| Q4 | - | -7% | -21.9% | 245.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.6 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -0.7 | 2 | 10.7 | -20 | 7.2 | 2.8 | -4.8 | -7.1 | - | - | - | 41.1 |
| 2023 | |||||||||||
| -54.6 | -41.6 | 48.6 | 4.8 | -9.3 | 2 | 3 | -10.7 | -33.7 | -23.6 | -11 | 15.7 |
| 2022 | |||||||||||
| -26.9 | -25.2 | 108.5 | -52.9 | -46.5 | -13.8 | 10 | -7.9 | 3534.9 | -42.5 | -16.7 | 621.2 |
| 2021 | |||||||||||
| 9.6 | -0.3 | -9 | 14.7 | -27.4 | -5.5 | -34.9 | -2 | -22.5 | -33.6 | 7.2 | -35.1 |
| 2020 | |||||||||||
| 61.2 | -10.5 | 63.1 | 13.3 | 23.6 | -14.6 | -16.8 | 1.7 | -12.6 | -15.1 | 13.3 | -9.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -7 | -22.5 | -0.5 | -0.5 |
| Q2 | -4.4 | -19 | -0.6 | -0.4 |
| Q3 | -3.4 | 19.3 | -0.4 | -0.5 |
| Q4 | 0 | -7.2 | -33.9 | -0.5 |
| A | -14.76 | -29.5 | -108.3 | -2 |